MLYS Mineralys Therapeutics, Inc.

Fundamentals / CIK 0001933414 / USD

Mineralys Therapeutics, Inc. reported $630.1M in total assets and a net loss of $370.0M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MLYS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$166.3MFY 2022 Net Income: -$29.80M2022FY 2023 Net Income: -$71.90M2023FY 2024 Net Income: -$177.8M2024FY 2025 Net Income: -$154.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $132.0M $168.6M $70.36M $26.25M
Total Operating Expenses $170.6M $192.4M $84.66M $31.48M
Operating Income -$170.6M -$192.4M -$84.66M -$31.48M
EBITDA -$170.5M -$192.4M -$84.66M --
Income Tax Expense $0 -- -- --
Net Income -$154.7M -$177.8M -$71.90M -$29.80M
Basic EPS -$2.29 -$3.66 -$1.99 -$62.31
Diluted EPS -$2.29 -$3.66 -$1.99 -$62.31
Basic Shares Outstanding 67.7M 48.5M 36.2M 478.5K
Diluted Shares Outstanding 67.7M 48.5M 36.2M 478.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $22.67M $221.4M $24.36M $24.40M $31.45M $38.28M $37.88M $44.57M
Total Operating Expenses $60.09M $246.0M $45.34M $38.28M $41.13M $46.75M $44.45M $51.77M
Operating Income -$60.09M -$246.0M -$45.34M -$38.28M -$41.13M -$46.75M -$44.45M -$51.77M
EBITDA -$60.08M -$246.0M -$45.33M -$38.27M -$41.12M -$46.73M -$44.43M -$51.75M
Interest Income $5.95M -- -- -- $4.20M -- -- --
Interest Expense $3.19M -- -- -- $0 -- -- --
Net Income -$57.33M -$241.1M -$39.34M -$32.23M -$36.93M -$43.27M -$42.21M -$48.95M
Basic EPS -$0.64 -$2.85 -$0.47 -- -$0.52 -$0.66 -$0.79 --
Diluted EPS -$0.64 -$2.85 -$0.47 -- -$0.52 -$0.66 -$0.79 --
Basic Shares Outstanding 89.0M 84.7M 82.8M -- 70.6M 65.5M 53.2M --
Diluted Shares Outstanding 89.0M 84.7M 82.8M -- 70.6M 65.5M 53.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $172.9M $114.1M $49.30M $87.70M
Cash & Short-Term Investments $172.9M $114.1M $49.30M $87.70M
Total Current Assets $661.4M $205.4M $249.1M $112.8M
Property, Plant & Equipment, Net $38K $53K $0 --
Long-Term Investments -- $0 $2.48M --
Other Non-Current Assets $382K $499K $51K $1.63M
Total Non-Current Assets $420K $552K $2.53M $1.63M
Total Assets $661.8M $205.9M $251.6M $114.4M
Accounts Payable $2.02M $479K $601K $1.91M
Total Current Liabilities $15.11M $14.65M $10.48M $8.07M
Total Non-Current Liabilities $0 $0 $0 $158.6M
Total Liabilities $15.11M $14.65M $10.48M $166.7M
Common Stock $8.0K $5.0K $4.0K $1.0K
Retained Earnings -$457.2M -$302.5M -$124.7M -$52.81M
Total Stockholders' Equity $646.7M $191.3M $241.2M -$52.27M
Total Equity $646.7M $191.3M $241.2M -$52.27M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $101.3M $138.3M $112.8M $172.9M $217.6M $101.8M $165.0M $114.1M
Cash & Short-Term Investments $101.3M $138.3M $112.8M $172.9M $217.6M $101.8M $165.0M $114.1M
Total Current Assets $628.0M $665.8M $652.5M $661.4M $599.8M $335.3M $354.5M $205.4M
Property, Plant & Equipment, Net $21K $27K $32K $38K $7.0K $22K $38K $53K
Long-Term Investments -- -- -- -- -- -- -- $0
Other Non-Current Assets $2.11M $2.02M $360K $382K $144K $433K $397K $499K
Total Non-Current Assets $2.13M $2.05M $392K $420K $151K $455K $435K $552K
Total Assets $630.1M $667.9M $652.9M $661.8M $599.9M $335.7M $354.9M $205.9M
Accounts Payable $738K $1.07M $1.12M $2.02M $1.12M $3.16M $373K $479K
Total Current Liabilities $53.08M $19.32M $14.72M $15.11M $23.52M $22.17M $13.39M $14.65M
Long-Term Debt $100K $100K -- -- -- -- -- --
Total Non-Current Liabilities $73.27M $97.62M $0 $0 $0 $0 $0 $0
Total Liabilities $126.3M $116.9M $14.72M $15.11M $23.52M $22.17M $13.39M $14.65M
Total Debt (incl. Leases) $100K $100K -- -- -- -- -- --
Common Stock $9.0K $9.0K $8.0K $8.0K $8.0K $6.0K $6.0K $5.0K
Retained Earnings -$794.9M -$737.6M -$496.5M -$457.2M -$424.9M -$388.0M -$344.7M -$302.5M
Total Stockholders' Equity $503.8M $550.9M $638.1M $646.7M $576.4M $313.6M $341.6M $191.3M
Total Equity $503.8M $550.9M $638.1M $646.7M $576.4M $313.6M $341.6M $191.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$154.7M -$177.8M -$71.90M -$29.80M
Depreciation & Amortization $59K $43K $0 --
Stock-Based Compensation $19.32M $11.34M $5.06M $455K
Operating Cash Flow -$142.4M -$166.3M -$81.17M -$29.22M
Capital Expenditure -$15K -$96K $0 --
Free Cash Flow -$142.4M -$166.4M -$81.17M --
Investing Cash Flow -$389.8M $115.0M -$160.5M -$21.76M
Financing Cash Flow $591.0M $116.1M $203.2M $128.0M
Net Change in Cash $58.83M $64.79M -$38.40M $77.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$57.33M -$241.1M -$39.34M -$32.23M -$36.93M -$43.27M -$42.21M -$48.95M
Depreciation & Amortization $6.0K $5.0K $6.0K $13K $15K $16K $15K $15K
Stock-Based Compensation $7.88M $7.36M $6.55M $5.29M $5.84M $4.55M $3.65M $3.13M
Operating Cash Flow -$43.10M -$32.56M -$39.47M -$37.89M -$28.87M -$30.17M -$45.49M -$66.84M
Capital Expenditure -- -- -- -$15K $0 $0 $0 $0
Free Cash Flow -- -- -- -$37.90M -$28.87M -$30.17M -$45.49M -$66.84M
Investing Cash Flow $4.70M -$185.2M -$44.94M -$103.5M -$150.5M -$42.88M -$92.88M $83.57M
Common Stock Issued -- -- -- -- -- -- $189.2M --
Financing Cash Flow $1.40M $243.3M $24.27M $96.70M $295.2M $9.83M $189.3M $90K
Net Change in Cash -$36.99M $25.49M -$60.14M -$44.68M $115.8M -$63.22M $50.92M $16.82M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -23.9% -93.0% -29.8% --
Return on Assets (ROA) -23.4% -86.4% -28.6% -26.0%
Current Ratio 43.76x 14.02x 23.76x 13.98x
Quick Ratio 11.44x 7.79x 4.70x 10.87x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -73.4% -63.5% -23.8% -23.9% -29.7% -60.8% -55.2% -93.0%
Return on Assets (ROA) -58.7% -52.3% -23.2% -23.4% -28.6% -56.8% -53.1% -86.4%
Current Ratio 11.83x 34.46x 44.33x 43.76x 25.50x 15.12x 26.48x 14.02x
Quick Ratio 1.91x 7.16x 7.66x 11.44x 9.25x 4.59x 12.33x 7.79x
Debt to Equity 0.00x 0.00x -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001933414) · from March 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:27 UTC · Open in terminal